What science can do with computer vision using cutting-edge XAI

Membership content

Phil Teare

In this article, Phil Teare, Director of Computer Vision at AstraZeneca, provides insights on how computer vision is used in a biopharma setting and how cutting-edge explainable artificial intelligence (XAI) is crucial to what AstraZeneca does, and how they do it. You’ll also learn about how XAI has been rapidly evolving, and how much scientific value it really delivers.

Written by:

Phil Teare

—

What science can do with computer vision using cutting-edge XAI

Our mission is to help develop the next generation of machine intelligence specifically focusing on accelerating AI at the edge.

For new and groundbreaking start-ups, we want to inspire and inform your journey, and for those giants in the space, we want to provide the tools you need to innovate and continue to propel your growth.